Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
Doylestown Health's Cancer Institute's Outpatient Infusion Unit offers a spacious and comfortable environment for patients with prostate cancer to receive advanced infusion care such as:
Penn Radiation Oncology Doylestown is an outpatient radiation treatment program located in The Pavilion on the main campus of Doylestown Hospital. As a Penn Medicine satellite location, we are equipped with the most advanced technology including a state-of-the-art linear accelerator, which is a computer-controlled device that delivers radiation therapies or radiotherapies.
Doylestown Health urologists work closely as a team with board-certified Penn radiation oncologists to treat your prostate cancer using advanced, precisely focused, high-energy rays, similar to X-rays, to target cancer in the prostate. Targeted radiation therapies limit radiation exposure to surrounding healthy tissue to minimize side effects such as urinary incontinence, bowel problems or sexual dysfunction. Therapies include:
Radical prostatectomy is the surgical removal of the prostate, a treatment approach used primarily when cancer is confined to the prostate gland. Our surgeons have extensive experience in the three major types of radical prostatectomy including:
Prostate cancer is often diagnosed early. Men over age 70 often choose a treatment option called watchful waiting or active surveillance. This approach repeats prostate-specific antigen (PSA) blood tests, rectal exams and periodic biopsies to monitor progression of the cancer. You may choose this option if you are not experiencing symptoms, and if your cancer is small, confined and expected to grow slowly. Many men live normal lives without treatment. Often, prostate cancer does not spread or cause problems.
Doylestown Health's Cancer Institute's Outpatient Infusion Unit offers a spacious and comfortable environment for patients with prostate cancer to receive advanced infusion care such as:
Penn Radiation Oncology Doylestown is an outpatient radiation treatment program located in The Pavilion on the main campus of Doylestown Hospital. As a Penn Medicine satellite location, we are equipped with the most advanced technology including a state-of-the-art linear accelerator, which is a computer-controlled device that delivers radiation therapies or radiotherapies.
Doylestown Health urologists work closely as a team with board-certified Penn radiation oncologists to treat your prostate cancer using advanced, precisely focused, high-energy rays, similar to X-rays, to target cancer in the prostate. Targeted radiation therapies limit radiation exposure to surrounding healthy tissue to minimize side effects such as urinary incontinence, bowel problems or sexual dysfunction. Therapies include:
Radical prostatectomy is the surgical removal of the prostate, a treatment approach used primarily when cancer is confined to the prostate gland. Our surgeons have extensive experience in the three major types of radical prostatectomy including:
Prostate cancer is often diagnosed early. Men over age 70 often choose a treatment option called watchful waiting or active surveillance. This approach repeats prostate-specific antigen (PSA) blood tests, rectal exams and periodic biopsies to monitor progression of the cancer. You may choose this option if you are not experiencing symptoms, and if your cancer is small, confined and expected to grow slowly. Many men live normal lives without treatment. Often, prostate cancer does not spread or cause problems.